Subcutaneous Insulin for Diabetic Ketoacidosis in Adults
Subcutaneous lispro for mild-to-moderate DKA reduces ED length of stay and costs without compromising safety.
DKA
-
Subcutaneous Insulin for Diabetic Ketoacidosis in Adults
Subcutaneous lispro for mild-to-moderate DKA reduces ED length of stay and costs without compromising safety. -
WATCH NOW: Highlights from ACEP15
Watch highlights of ACEP15. -
ACEP15: How to Manage a Diabetic Emergency
BOSTON—Diabetic ketoacidosis (DKA) literally hits home for Chandra Aubin, MD, associate professor of Washington University School of…